---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-113486"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T07:02:10.902921+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TriSalus: Director Anil Singhal resigns; CMO Steven Katz departs

## Summary
- Director Anil Singhal resigned from Board, Compensation and Science/Technology committees effective Oct 28, 2024; no disagreement.
- Chief Medical Officer Steven Katz left employment effective Oct 29, 2024.
- No replacements announced for either role, creating two leadership vacancies.

## SEC filing metadata
- accession: 0001104659-24-113486
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/0001104659-24-113486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/tm2427190d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-113486
- JSON: https://secwatch.observer/filing/0001104659-24-113486.json
- Plain text: https://secwatch.observer/filing/0001104659-24-113486.txt

## Key facts
- Executive change
  Steven Katz departed as Chief Medical Officer at TriSalus Life Sciences, Inc..
  - Action: no longer employed
  - Role: Chief Medical Officer
  source text: Effective October 29, 2024, Steven Katz, M.D., the Company’s Chief Medical Officer, is no longer employed by the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/0001104659-24-113486-index.htm
- Executive change
  Anil Singhal resigned as Director at TriSalus Life Sciences, Inc..
  - Action: resigned
  - Role: Director
  source text: On October 28, 2024, Anil Singhal, Ph.D., informed the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) of his decision to resign from his position as a member of the Board, the Compensation Committee of the Board and the Science and Technology Committee of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/0001104659-24-113486-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.